| | Before | After | P value |
|---|
VLFMAP (mmHg2) | 6.41 ± 1.20 | 6.61 ± 1.23 | 0.91 |
VLFvel (cm2/s2) | 4.30 ± 1.06 | 3.92 ± 0.96 | 0.58 |
CohVLF (unit) | 0.52 ± 0.04 | 0.50 ± 0.04 | 0.56 |
GainVLF (cm/s/mmHg) | 0.63 ± 0.10 | 0.53 ± 0.08 | 0.37 |
PhaseVLF (radians) | 1.41 ± 0.10 | 1.41 ± 0.17 | 0.97 |
LFMAP (mmHg2) | 2.50 ± 0.45 | 2.55 ± 0.49 | 0.93 |
LFvel (cm2/s2) | 1.19 ± 0.22 | 1.43 ± 0.20 | 0.20 |
CohLF (unit) | 0.51 ± 0.06 | 0.58 ± 0.06 | 0.18 |
GainLF (cm/s/mmHg) | 0.54 ± 0.07 | 0.69 ± 0.09* | 0.048 |
PhaseLF (radians) | 0.63 ± 0.16 | 0.81 ± 0.13 | 0.50 |
HFMAP (mmHg2) | 0.25 ± 0.06 | 0.18 ± 0.04 | 0.29 |
HFvel (cm2/s2) | 0.25 ± 0.05 | 0.23 ± 0.06 | 0.82 |
CohHF (unit) | 0.61 ± 0.05 | 0.63 ± 0.06 | 0.74 |
GainHF (cm/s/mmHg) | 0.80 ± 0.05 | 0.92 ± 0.09* | 0.046 |
PhaseHF (radians) | − 0.01 ± 0.10 | 0.01 ± 0.04 | 0.79 |
- Values are means ± SEM. Before before the 14-day confinement period in an isolated environment, After after the 14-day confinement period in an isolated environment, VLFMAP very low-frequency component of mean arterial blood pressure (MAP) variability, VLFvel very low-frequency component of mean cerebral blood flow velocity (MCBFV) variability, CohVLF coherence in the very low-frequency range, GainVLF transfer function gain in the very low-frequency range, PhaseVLF phase in the very low-frequency range, LFMAP low-frequency component of MAP variability, LFvel low-frequency component of MCBFV variability, CohLF coherence in the low-frequency range, GainLF transfer function gain in the low-frequency range, PhaseLF phase in the low-frequency range, HFMAP high-frequency component of MAP variability, HFvel high-frequency component of MCBFV variability, CohHF coherence in the high-frequency range, GainHF transfer function gain in the high-frequency range, PhaseHF phase in the high-frequency range. *P<0.05 comparison between before and after the 14-day confinement period in an isolated environment
